Clinical Trials Directory

Trials / Completed

CompletedNCT01818453

Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?

Genetic Predictors of Response to a Computerized Self-help Program for Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The goal of this project is to determine whether genetic information can be used to predict response to an internet-based treatment of depression. Several studies now indicate that completing an internet-based treatment for depression, called Deprexis, can significantly improve symptoms of depression. However, not everyone improves. The purpose of this study is to determine whether genetic profile can predict who is likely to improve.

Conditions

Interventions

TypeNameDescription
BEHAVIORALComputerized self-help program for depressionFor 8 weeks, participants will engage in a computerized self-help program for depression, called deprexis. This program consists of 10 content modules representing different psychotherapeutic approaches broadly consistent with a cognitive-behavioral perspective. Modules are organized as simulated dialogues in which the program explains and illustrates concepts and techniques, engages the user in exercises, and continuously asks users to respond by selecting from response options. Subsequent content is then tailored to the users' responses, resulting in a simulated conversational flow. Participants can access the self-help program as often as they would like and since it is self-guided, they will determine how often they access the material. Each module can be completed in 10 to 60 minutes, depending on the user's reading speed, interest, motivation, and individual path through the program.

Timeline

Start date
2013-03-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2013-03-26
Last updated
2015-11-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01818453. Inclusion in this directory is not an endorsement.